Previous 10 | Next 10 |
Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...
Following a sharp rally on Monday thanks to its popularity on social media, Longeveron (LGVN -32.7%) has lost more than a quarter of value in morning hours on above-average volume. Over ~8.8M Longeveron (NASDAQ:LGVN) shares have changed hands compared to the 65-day average volume of ~8.0M sha...
Shares of Longeveron (LGVN +165.9%), which began a dramatic rise on Nov. 18 following Rare Pediatric Disease ("RPD") designation for Lomecel-B, are continuing to skyrocket. On Nov. 18, shares closed up 135%. The following day, the closed up another 46%. The RPD designation is for Hy...
Check Out These 4 Trending Biotech Stocks Right Now Biotech stocks have been among the most exciting stocks to invest in the stock market . The reason being, this is a high-risk, high-reward industry that could appeal to a certain group of investors. The stock movement within th...
Longeveron Inc ( NASDAQ: LGVN ) is a clinical biotech firm that develops cellular therapies to treat life-threatening and aging-related conditions. It announced that it had received approval from the FDA for the RPD (Rare Pediatric Disease) designation for its Lomecel-B to treat...
Gainers: Greenland Technologies Corporation (NASDAQ:GTEC) +71%. Longeveron (NASDAQ:LGVN) +37%. Aurora (NASDAQ:AUR) +31%. Bakkt (NYSE:BKKT) +26%. FedNat Holding Company (NASDAQ:FNHC) +18%. UWM Holdings Corporation (NYSE:UWMC) +18%. SCYNEXIS (NASDAQ:SCYX) +16%. Kornit (NASDAQ:KRNT) +15%. Aspira...
Gainers: Longeveron (NASDAQ:LGVN) +36%, SCYNEXIS (NASDAQ:SCYX) +16%, Context Therapeutics (NASDAQ:CNTX) +15%, Akoya Biosciences (NASDAQ:AKYA) +15%, Aspira Women's Health (NASDAQ:AWH) +15%. Losers: Connect Biopharma (NASDAQ:CNTB) -54%, Flora Gr...
On the heels of a 135% gain yesterday, shares of Longeveron (NASDAQ:LGVN) are up another 75% in premarket trading. Shares skyrocketed yesterday after the company recveived FDA Rare Pediatric Disease Designation for Lomecel-B, its candidate for Hypoplastic Left He...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday! Source: Shutterstock There’s plenty of news moving stock today...
3 Penny Stocks to Add to Your November 2021 Watchlist While November is more than halfway done, penny stocks continue to see bullish momentum. Although it has been a shaky month and past few months for both penny stocks and blue chips , it’s clear that investors are hoping fo...
News, Short Squeeze, Breakout and More Instantly...
Longeveron (NASDAQ: LGVN) , a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, has closed on its previously announced registered direct offering. The offering, which was priced at-the-market ...
MIAMI, July 19, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today ann...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...